SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,948.80 -523.53
( -0.72%)

Global Indices

Nasdaq

51,671.07 418.43
(0.82%)

Dow Jones

7,831.57 45.21
(0.58%)

Hang Seng

69,084.74 42.63
(0.06%)

Nikkei 225

10,559.70 118.10
(1.13%)

Forex

USD-INR

96.78 0.11
(0.12%)

EUR-INR

108.39 0.07
(0.07%)

GBP-INR

127.86 0.00
(0.00%)

JPY-INR

0.61 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

28.09

62953.96

EPS(TTM)

Face Value()

Div & Yield %

187.45

1.01

Back

Shriram Finance consolidated net profit rises 59.89% in the June 2026 quarter

Jul 24,2026

Net profit of Shriram Finance rose 59.89% to Rs 3452.77 crore in the quarter ended June 2026 as against Rs 2159.40 crore during the previous quarter ended June 2025. Sales rose 15.96% to Rs 13229.11 crore in the quarter ended June 2026 as against Rs 11408.20 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	13229.11	11408.20	16
OPM %	75.55	74.28	-
PBDT	4808.51	3079.34	56
PBT	4625.72	2906.23	59
NP	3452.77	2159.40	60

71,948.80 -523.53 ( -0.72%)

51,671.07 418.43 (0.82%)

7,831.57 45.21 (0.58%)

69,084.74 42.63 (0.06%)

10,559.70 118.10 (1.13%)

96.78 0.11 (0.12%)

108.39 0.07 (0.07%)

127.86 0.00 (0.00%)

0.61 0.00 (0.21%)